Godavari Biorefineries has secured a patent from the European Patent Office for its invention, “Pharmaceutical Composition and a Process to Prepare the Same”. The patent covers a pharmaceutical composition that combines anti-cancer compounds with a solubilising agent, along with the process to prepare it.
The composition is designed to enhance the solubility and bioavailability of the active compounds, thereby improving their therapeutic potential. It has applications in the treatment of various cancers, including breast and prostate cancers, particularly through oral administration.
The patent adds to Godavari Biorefineries Limited’s oncology-focused intellectual property portfolio.
“In oncology research, identifying a promising compound is only one part of the challenge. How that compound is formulated can determine how effectively it can be developed for therapeutic use. Our research has focused on improving the solubility and bioavailability of these compounds, and the grant of this European patent is an important recognition of that work,” said Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited.
Commenting on the achievement, Samir Somaiya, Chairman and Managing Director, Godavari Biorefineries Limited said, “Our approach to innovation has always been guided by a larger purpose, to advance health, wellbeing and sustainability while creating lasting value for all. The Sanskrit mantra ‘सर्वे सन्तु निरामयाः’, meaning ‘Health for All’, reflects this purpose and reminds us that the true value of innovation lies in its ability to improve lives. As we look beyond our traditional businesses, our investments in R&D are enabling us to build capabilities in areas where science and technology can address meaningful societal needs. This European patent is an important milestone in that journey, strengthening our intellectual property and opening possibilities for developing solutions with potential applications in healthcare. For us, innovation is meaningful when it creates sustainable opportunities for the business while also contributing to a healthier and more sustainable future for society.”
The European grant further expands Godavari Biorefineries’ international intellectual property footprint as the company continues to protect its research across major markets worldwide.